BAX · Baxter International Inc · Webcasts, Transcripts & Audio
$25.55
-0.10 (-0.39%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$13.27B
Shares
517.35M
Volume · Nov 5
10.1M
Avg daily vol (3M)
6.65M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Baxter International Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Baxter International Inc (BAX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-10-29
Baxter International Inc (BAX) Q3 2026 Earnings Call Transcript
Positive tone
Inflation, tariffs, and 2027 headwinds
Advanced surgery and drug compounding growth
Raised 2026 financial outlook
Revenue
$2.98B
▲ 5% YoY Diluted EPS
$0.57
Gross margin
33.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-07-30
Baxter International Inc (BAX) Q2 2026 Earnings Call Transcript
Positive tone
Strategic priorities and turnaround
Tariff refund and EPS outlook
Organic revenue growth and Q2 results
Revenue
$2.96B
▲ 5.3% YoY Diluted EPS
$0.24
▲ 33.3% YoY Gross margin
34.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Baxter International Inc (BAX) June 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-13
Baxter International Inc (BAX) May 13, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-05-05
Baxter International Inc (BAX) May 5, 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Baxter International Inc (BAX) Q1 2026 Earnings Call Transcript
Positive tone
Novum LVP field actions and remediation
Leadership and CFO search
Balance sheet and cash flow / leverage
Revenue
$2.70B
▲ 2.9% YoY Diluted EPS
$-0.03
▼ 112% YoY Gross margin
33.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-11
Baxter International Inc (BAX) March 11, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-12
Baxter International Inc (BAX) Q4 2025 Earnings Call Transcript
Cautious tone
2026 guidance and macro/tariffs
Balance sheet and deleveraging
Operating model restructuring
Revenue
$2.97B*
▲ 8% YoY Gross margin
19.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-30
Baxter International Inc (BAX) Q3 2025 Earnings Call Transcript
Cautious tone
CEO transition and stabilization
Fluid conservation and inventory
Balance sheet and dividend cut
Revenue
$2.83B
▲ 5% YoY Diluted EPS
$-0.09
▼ 133.3% YoY Gross margin
33.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
Baxter International Inc (BAX) Q2 2025 Earnings Call Transcript
Cautious tone
Operating margin / cost pressure
IV fluid conservation
North Cove / Vizient partnership
Revenue
$2.81B
▲ 4.3% YoY Diluted EPS
$0.18
Gross margin
35.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Baxter International Inc (BAX) Q1 2025 Earnings Call Transcript
Positive tone
Kidney Care / Vantive divestiture
2025 financial outlook
Hurricane Helene / North Cove IV recovery
Revenue
$2.62B
▲ 5.4% YoY Diluted EPS
$0.25
▲ 257.1% YoY Gross margin
32.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-03
Baxter International Inc (BAX) Q4 2024 Earnings Call Transcript
Confident tone
2024 results and 2025 outlook
Hospital products and therapies segments
North Cove hurricane recovery
Revenue
$2.75B
▲ 0.9% YoY Diluted EPS
$-1.00
▼ 308.3% YoY Gross margin
34.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Baxter International Inc (BAX) Q3 2024 Earnings Call Transcript
Positive tone
Kidney Care Divestiture
2025 Financial Outlook
North Cove Hurricane Recovery
Revenue
$2.70B
▲ 3.8% YoY Diluted EPS
$0.27
▼ 94.5% YoY Gross margin
38.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Baxter International Inc (BAX) Q2 2024 Earnings Call Transcript
Positive tone
Strategic transformation and Kidney Care separation
2025 outlook and exit rate
Front Line Care / primary care softness
Revenue
$2.69B
▲ 4% YoY Diluted EPS
$-0.61
Gross margin
38.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Baxter International Inc (BAX) Q1 2024 Earnings Call Transcript
Positive tone
Geographic expansion of Hillrom / HST internationally
Margin improvement and supply chain execution
Healthcare Systems & Technologies (HST) underperformance
Revenue
$2.49B
▲ 2% YoY Diluted EPS
$0.07
▼ 22.2% YoY Gross margin
38.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Baxter International Inc (BAX) Q4 2023 Earnings Call Transcript
Positive tone
Pricing and GPO contracts
Kidney Care / Vantive separation
Segment performance (Medical Products, HST, Pharmaceuticals)
Revenue
$2.73B
▼ 27.1% YoY Diluted EPS
$0.48
▲ 33.3% YoY Gross margin
40.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Baxter International Inc (BAX) Q3 2023 Earnings Call Transcript
Revenue
$2.60B
▼ 28% YoY Diluted EPS
$4.93
Gross margin
40.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Baxter International Inc (BAX) Q2 2023 Earnings Call Transcript
Revenue
$2.59B
▼ 27.9% YoY Diluted EPS
$-0.28
▼ 156% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
Baxter International Inc (BAX) Q1 2023 Earnings Call Transcript
Revenue
$2.44B
▼ 31.4% YoY Diluted EPS
$0.09
▼ 35.7% YoY Gross margin
39.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-09
Baxter International Inc (BAX) Q4 2022 Earnings Call Transcript
Revenue
$3.75B
▲ 30.2% YoY Diluted EPS
$0.36
Gross margin
37.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Baxter International Inc (BAX) Q3 2022 Earnings Call Transcript
Revenue
$3.61B
▲ 11.9% YoY Diluted EPS
$-5.83
▼ 755.1% YoY Gross margin
29.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Baxter International Inc (BAX) Q2 2022 Earnings Call Transcript
Revenue
$3.59B
▲ 16% YoY Diluted EPS
$0.50
▼ 15.3% YoY Gross margin
38.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Baxter International Inc (BAX) Q1 2022 Earnings Call Transcript
Revenue
$3.56B
▲ 20.8% YoY Diluted EPS
$0.14
▼ 75.9% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Baxter International Inc (BAX) Q4 2021 Earnings Call Transcript
Revenue
$2.88B*
▼ 9.6% YoY Gross margin
35.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Baxter International Inc (BAX) Q3 2021 Earnings Call Transcript
Revenue
$3.23B
▲ 8.5% YoY Diluted EPS
$0.89
▲ 29% YoY Gross margin
40.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript
Revenue
$3.10B
▲ 14% YoY Diluted EPS
$0.59
▲ 22.9% YoY Gross margin
39.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Baxter International Inc (BAX) Q1 2021 Earnings Call Transcript
Revenue
$2.95B
▲ 5.1% YoY Diluted EPS
$0.58
▼ 9.4% YoY Gross margin
38.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Baxter International Inc (BAX) Q4 2020 Earnings Call Transcript
Revenue
$3.18B
▲ 4.7% YoY Diluted EPS
$0.33
Gross margin
37.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Baxter International Inc (BAX) Q3 2020 Earnings Call Transcript
Revenue
$2.97B
▲ 4.2% YoY Diluted EPS
$0.69
▼ 2.8% YoY Gross margin
40.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Baxter International Inc (BAX) Q2 2020 Earnings Call Transcript
Revenue
$2.72B
▼ 4.1% YoY Diluted EPS
$0.48
▼ 20% YoY Gross margin
38.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Baxter International Inc (BAX) Q1 2020 Earnings Call Transcript
Revenue
$2.80B
▲ 6.2% YoY Diluted EPS
$0.64
▼ 3% YoY Gross margin
41.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-17
Baxter International Inc (BAX) Q4 2019 Earnings Call
Revenue
$3.04B
▲ 7.3% YoY Diluted EPS
$-0.05
▼ 108.8% YoY Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–32 of 32 webcasts
Key facts
CIK
10456
CUSIP
071813109
13F (30d)
406 filings
349 filers
Visit website
Investor relations